Exhibit 31.2

I, Andrew J. Norstrud, certify that:

     1.  I  have  reviewed  this  quarterly  report  on Form 10-QSB of Stem Cell
Therapy  International,  Inc.

     2. Based on my knowledge, this report does not contain any untrue statement
of  a  material  fact  or  omit  to  state a material fact necessary to make the
statements  made,  in  light  of  circumstances under which such statements were
made,  not  misleading  with  respect  to  the  period  covered  by this report;

     3.  Based on my knowledge, the condensed consolidated financial statements,
and  other  financial information included in this report, fairly present in all
material  respects the consolidated financial condition, consolidated results of
operations  and  consolidated cash flows of the small business issuer as of, and
for,  the  periods  presented  in  this  report;

     4.  The  small  business  issuer's  other  certifying  officers  and  I are
responsible  for establishing and maintaining disclosure controls and procedures
(as  defined  in  Exchange  Act  Rules  13a-15(e)  and  15d-15(e)) for the small
business  issuer  and  have:

          a)  designed  such  disclosure controls and procedures, or caused such
     disclosure controls and procedures to be designed under our supervision, to
     ensure  that  material  information  relating to the small business issuer,
     included  its  consolidated  subsidiaries,  is  made  known to us by others
     within  those entities, particularly during the period in which this report
     is  being  prepared;

          b)  evaluated  the  effectiveness  of  the  small  business  issuer's
     disclosure  controls  and  procedures  and  presented  in  this  report our
     conclusions  about  the  effectiveness  of  the  disclosure  controls  and
     procedures,  as  of  the  end of the period covered by this report based on
     such  evaluation;

          c)  disclosed in this report any change in the small business issuer's
     internal  control  over  financial reporting that occurred during the small
     business  issuer's most recent fiscal quarter that has materially affected,
     or  is  reasonably likely to materially affect, the small business issuer's
     internal  control  over  financial  reporting;  and

     5.  The  small  business  issuer's  other  certifying  officers  and I have
disclosed,  based  on  our  most  recent  evaluation  of  internal  control over
financial  reporting,  to  the  small  business  issuer's auditors and the audit
committee  of  small business issuer's board of directors (or persons performing
the  equivalent  functions):

          a)  all significant deficiencies and material weaknesses in the design
     or  operation  of  internal  control  over  financial  reporting  which are
     reasonably  likely to affect the small business issuer's ability to record,
     process,  summarize  and  report  financial  information;  and

          b)  any  fraud,  whether  or not material, that involves management or
     other  employees who have a significant role in the small business issuer's
     internal  control  over  financial  reporting.


                        Chief Financial Officer and Chief
/s/Andrew J. Norstrud   Accounting Officer                  February 19, 2008
---------------------   ---------------------------------   -----------------

                                      21